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THE EFFECT OF SODIUM COLISTINEMETHANESULFONATE
ON STRAINS OF PSEUDOMONAS
JOSEPH

P.

Ph.D.*

TRU,\NT,

An antibiotic produced by the soil-borne Bacillus polymyini.xa var colistinus
I Bacillus (aerorobacillus) colistinus) w as isolated from a soil sample (Fukychinia
I'refecture, Japan) by Koyama ci al in 1950." The drug was given the generic name
'listin. Two forms are commercially available: (1) colistin sulfate (Coly-mycin
S * • ) and (2) sod ium colistinmethanesultonate

(Col\-mycin M * * ) . These are

complex polypeptide antibiotics which have chemical propeHies

related to those

of polymyxin', Shidlovsky ei aP have stated that Ihe principle amino acids of coli.stin
are as follows: l-lhreonine, d-l-leucine and

l-alph,i, gamnui-tli-aminobu(yrie acid

I does not contain either d-serine or phenylalanine
.Sodium colislinmethanesulfonate and colistin sulfate are said to have m.irked
b.iaeriostitic and bactericidal activity in vitro against such groups of gram neyalive
nisms a.s Pseudomonas. Saliiiimclla. Shigella, Escherichia and others.' The compounds apparently have less activity against gram positive bacteria and fungi.
During the last decade the clinical picture of infectious disease has underi;one
a rapid and rather dramatic change from a position ot immediate concern for such
virulent organisms as the pneumococci and streptococci to one of minor clinie.il
ini|V'rlance for these pathogens. Ihe rise to a position of importance by organisms
formerly considered as saphrophyles or minor pathogens is well illustrated by the
fact that organisms such as .Aerobiu u-r. Escherichia. Proteus and I'wiidomonas are
beini; found with increasing frequency in infections (i.e. urinary tract). Pseii<h>nu>na\
is commonly found in refractory infections. It is frequently found when foreign hoilies
have been introduced or if there are deficient host resistance faclors associated with
calculi, urinary tract obstruction, drains, catheters, metastatic carcinomas, etc. Furthermore, it should be understood that treatment with chemotherapy of any type,
frequently fails unless the underlying cause for the infection is removed — i.e. obstmction in urinar\ tract infections.
Ihe present paper will be primarily concerned with the in vitro effect of colistin
un clinical isolates of the eenus Pseudomonas.
MATERIALS AND Ml I HODS
The antibiotic was supplied in vials containing sodium colisiinmelh.inesullon.iie
'coly-mycin-M). Each vial contained 150 mg. of colistin base as sodium colisiin"ii-'tlianesulfonate. One milligram of the pure colimycin base contains 30,000 units,
^'Department of Laboratories, Henry Ford Hospital, Detroit, Michigan,
Coly-mycin-S and Coly-mycin-M were supplied by Warner-Lamt>ert Research Institute, Moiris
'"'am. New Jersey.
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I h • i.oncentrations of ci>listin in this report have been expressed throughout as follows:
I . 2. It). 20, 50 and KM) micrograms (ug) of colimycin base per milliliter (ml.) of
diluent for the tube dilution as well as the cup-plate procedures. The lyophilized antibiotic V .,s reeonsiitiited with phosph.ite huller ( Ph 7,3). Ihis compound was ordinarily
reconstituted and used on the same day. Commercially available preparations of the
other ( hemotherapeutic agents were supplied by Mr. Fink of the Chas. Pfizer and
Company.*
llie i>rganisms tested were recent isolates from patients, whose specimens were
submitted to our bacteriology laboratory. Twenty-eight recently isolated strains of
/'M iiili>in<)nii\ were examined.
Ihe organisms were isolated on sheep's blood trypticase soy agar plates which
wen- .ilso used lor performing disk susceptibility tests with all chemotherapeutic,
agents except the sullonamide drugs, lube dilution and cup-plate assay studie
were perlormed using Bacto-S-R
broih and agar respectively.
liisio-S-R agar was also used tor the susceptibility tests empUning sullonamid
disks Ihe tests with the laller \yere read after 18 hours incubation at 37° C. Th '
results ot Ihe lube dilution were recorded at 24, 48, and 72 hours afler incubatio i
at 37° C. The size of the zone of inhibilion was measured with a caliper an I
recordeil in millimeters (mm.).
I In- inoeulum lor llie tube dilulions eonsisleil of 0,1 ml.
lated into 10 ml, of broth containing the antibiotics. Ihe
piep.'ied lo deieimine inoculum si/e showed approximately
of 4-hour cullute. Therefore, each tube was inoculated with
cells ot I'wudoiuonas.

of a 4-hour culture inocuplalc counts which were
25 million cells per ml,
approximatcK 2,500.()(iO

RESULTS
Ihe i/l \iin< spectr.i ol soilium colistinmeth.uiesulfonate

as well as other chemo-

ihei.,peuiic .ojenls' were delermineil using 28 recently isolated strains of Pseudomonas
Ihe minimum inhibitory concentrations (MIC) obtained by the tube dilution technique
.ig.iiiist some ol the siriiins .iie shown in table I, Ihe organisms ilesignaled in this
i.ible tepiesent

.i cross seclion ol the low, mean and high inhibitory

I M I C I obtained with 10 of the 28 strains of

concentrations

Pseudomonas.

Ihe tesulls ol the lube diluliiMi series ( I ,ible 1) show that the majority of strains
weie seiisiiixe to 20 micrograms of coly-mycin-M per ml. A few such as strain no. 7
,ind

weie resist,nit to 20 and 50 ug. per ml. respectively. Inspection of the table 1

and 2 will show that the cup-plaic ass;i\ results compare favorably with the values
obt.iitieil with Ihe tube dilution lechnique. The MIC figures in Table 2 further serve
to siuuv veiv exeelleiii correl.ition between the two procedures except for an occasional
strain (i.e. no. 6.1.
- I ti.i< I'li/i-r .11,1 ( ..!:,|'on. III. Hiool^Kii
N y
••Bacli>-S R medium *.\\ obtained from Difco I ,iboralocics. IX-lroit.
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TABLE 1
A cross-seclion of P.seudomonas strains and their M I C values usins; colv-mvcin-M,

1 ug*

Tube dilution melhod
2
10
20
50

100

1 ug*

Cup-platc pioceduie
2
10
:(>
5(1

100

Strain no.

+**
+

-

+

-

-

-f-

-

-

-

-

+

T-

-1-

-

-

-

-

•

1

^

-1-

-+-

-

-

-

+

-f-

-f-

+

-

-

11

-f

+

-t-

-

-

-

14

-1-

•

-

-

-

-

17

+

-

-

-

-1-

•f

-

—

——

1
2
3
4

18

+

23

•

-f

+

10 m m .

I.S

16

12

17

18

-f

9

12

15

+

10

12

15

-1-

9

12

13

+

•

10

12

14

+

10

14

17

18

+

+

4

•t-

111

11

<

-r

-1-

10

10

1.1

-1

-1-

10

u

16

-f-

+

•

+

+

-1-

9

Concentration of sodium colistinmelhanesulfonate is expresseil in micrograms (ug) per iiiillililer,
• = growth of organisms — no inhibitory effect.
— = no growth of organisms — inhibitory effect.
0 = numbers refer to the size of the zone of inhibition in millimeters (mm.).
cylinders are 8 mm. in diameter.

The slainless steel

TABLE 2
Miniiiuiiii inhibitory concentrations ( M I C ) of sodium colistinemelhanesullonate
using a cross-section of Fsvutloiuonas strains.
Strain no.
5

Tube dilution melhod

Cup-platc procedure

> 2 ug*

>2 ug*

2

20

8

10

10

9

10

10

10

2

10

12

2

2

15

20

20

24

10

10

27

2

10

28

10

10

'The MIC values are greater lhan the values shown in the table but less lhan the next laifiest tube
dilution or cup-plate value shown in Table 1. ie. The M I C for strain *5 is between 2 aiul 10 ug,
'•mce 2 ug, did not inhibit growth whereas 10 ug. produced inhibilion.
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Experience with the determination of MIC values against a variety of organism^
h.is shown that titration end points with Coly-mvcin-M and in fact with many othe
antibiotics depend on such conditions as (a) size of inoculum, (b) type of medi:i,
(c) effect of Ph. etc. For example Swartz et aP have studied the i>i vitro activity cf
colistin using various sizes of inoculum. They demonstrated that if the inoculu i
size varied from 10' to 10' the MIC values for sodium colistinemethanesulfonate would
vary from 0.03 to 10.0 ug per millimeter respectively. Since the inoculum size and
media used for the tube ililulion and cup-plate procedures was not exactly simil ir
with those of Sw.iri/ t l <//,' ihcse ma\ be possible reasons for the variation. The same
investig.itors reported that sodium colistinemethanesulfonate was up to 10 times more
active al Ph 6 1) than at 8.0 when evaluated in terms of the size of the inhibition zone.
The media (broth and agar) used in our series of experiments had a Ph range of 7.3
to 7.4. Therefore, it is unlikely that Ihe PH factor contributed significantly to the
occasional dilfcrences in MIC values obtained with the two techniques.
.Another aspect considered in ihis series of experiments was Ihe antibacterial
aclion of colistin. Our experiences has shown that the antibaclerial activity of the
drug IS prini.irih bacteriostatic rather lhan baclericidal. The bactericidal activity was
demonsir.ited by the //; vitro technique of subculturing from Ihe tubes that showed
no i;rowth in Ihe broth dilution series. The bacleriostatic and baclericidal concentrations,
for the sensitive organisms, were different in b6'?f of the series lested.
The results with colistin also essentially agree with the information published by
sever.il investig.itors who have studied the properties of poly-myxin."' Repeated tests
with these .igenis, using similar strains, showed slight but not significant variations in
Ihe bactericidal concern rations for many of the organisms; however, there were
sever.i! exceptions. Sodium colistinmelhanesulfonate and polymyxin B were gener.illy
more elfeelive bactericidal agents than dihydroslreptomycin. The data also demonstraled
lhat dihvdrostreptomvcin resistant strains of Pseudoinona\ may be sensitive to either
colistin or polymyxin B.
DISC USSION
Sevei.il riivestiu.iiois"" have studied the in vitro activity of the broad spectrum
.mtihioties I chlor.iniphenicol, tetracycline, etc.) as well as the sulfonamides (sulfanilamide, siili.ipv ridine) using a large variety of Pseudomonas isolates. In general, the'
lepoits h.ixe shown a stead\ increase in the incidence of organisms which have developed
resisi.ince lo these cheniotherapeutic agents. As a result, clinicians have frequenth
had no olher choice th.m to use the relatively more toxic antibiotics—i.e. bacitracin,
neonivern and poKmvxin Ihese agents have proven to be successful in the Ireatmcni
ot vonie l ' \ , iidiim(>iui\ tnlections. especially those resistant lo the common therapeutiv
ii:er t- Ihe studies of .Schwartz et aP and Roheris et aP* indicate that colistin sulfate
.md sodium eolistinenieth.uiesulfonate may possibly fill an important therapeutic need
in this clinical area.
Moie icscnilv eolrstin h.is been ei^nsideied as an .mlisepiic for preparation
the Kmel previous to surgerv
absorption of colistin from the gastrointestinal iravi
following oral administration is negligible, a characteristic which precludes its effective
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ness, by this route, for systemic infections but is advantageous when the antibiotic is
employed for the purpose of sterilization of the large bowel.' Shidlovsky et aP disclosed
that 400 mg, of colistin administered orally in one day reduced the total amount ot
gram negative organisms to a greater extent than did the smaller dosage of 200 mg.
They suggested that 2 grams erythromycin propionate be given in four equal divided
doses in one day as well as 400 mg. of colistin in order to give a greater and mote
consistent reduction of the gram positive flora. The authors did not ob.serve any
untoward reactions in any of the 21 patients during the course of treatment and
the observation period.
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SUMMARY
1. Sodium colistinemethanesulfonate
strains of
Pseudomonas.
2. The drug demonsir:iied

showed

baclericidal

3. Sodium colistinemethanesulfonate
against the strains which were examined.

antibacterial

activity

as well as bacteriostatic

/'/; \iiro

activity

against

in

vitro.

was slightly less active than polymyxin B
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